| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.5 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |